VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,194 | -9.1% | 16,639 | +33.1% | 0.00% | 0.0% |
| Q2 2023 | $202,674 | +34.0% | 12,503 | +37.7% | 0.00% | 0.0% |
| Q1 2023 | $151,232 | +147.9% | 9,083 | -55.2% | 0.00% | – |
| Q1 2022 | $61,000 | -34.4% | 20,294 | 0.0% | 0.00% | – |
| Q4 2021 | $93,000 | +82.4% | 20,294 | +149.0% | 0.00% | – |
| Q3 2021 | $51,000 | +4.1% | 8,149 | 0.0% | 0.00% | – |
| Q2 2021 | $49,000 | -5.8% | 8,149 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +13.0% | 8,149 | 0.0% | 0.00% | – |
| Q4 2020 | $46,000 | -2.1% | 8,149 | 0.0% | 0.00% | – |
| Q3 2020 | $47,000 | -20.3% | 8,149 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $59,000 | +227.8% | 8,149 | +106.9% | 0.00% | – |
| Q1 2020 | $18,000 | -43.8% | 3,939 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | +18.5% | 3,939 | 0.0% | 0.00% | – |
| Q3 2019 | $27,000 | -18.2% | 3,939 | 0.0% | 0.00% | – |
| Q2 2019 | $33,000 | -15.4% | 3,939 | 0.0% | 0.00% | – |
| Q1 2019 | $39,000 | +30.0% | 3,939 | 0.0% | 0.00% | – |
| Q4 2018 | $30,000 | – | 3,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |